Joseph Tyler, MS, Consultant at Pharmsupply Inc.
Brian Tham, Biotechnology Consultant at Pelegrine Bio.
On November 22nd, Nephron hosted a KOL call on the bioprocessing industry. Bioprocessing has historically been one of the fastest growing areas of our coverage, and we think the long-term outlook is bright. However, the industry is facing some short-term headwinds from excess inventory and the roll-off of demand for COVID-19. Topics of discussion on this conference call included an overview on the environment for bioprocessing purchasing, stocking trends, demand dynamics from COVID-19, views on various suppliers and product categories, and a discussion on quality of CDMO participants. Both of our experts have significant experience as industry consultants in helping customers establish biologics manufacturing and evaluate these big debates.
